OncoSeq® C

OncoSeq® C offers a comprehensive range of molecular genetic
analysis reports that help identify genetic variations that could be
associated with cancer development.

The OncoSeq® C reports are only generated by accredited and approved
partner laboratories that follow strict international quality guidelines.

OncoSeq® C Reports

OncoSeq®  C offers comprehensive clinical reports with clinically relevant findings for a variety of hereditary cancers.

Report

OncoSeq®  C Breast

OncoSeq® C Prostate

Cancer(s)

Breast, Ovarian

Prostate

Gene

Covering 3000+ genetic hotspots over 10 genes associated with breast and ovarian cancer including the ATM, BRCA1, BRCA2, KRAS, MLH1, MSH2, MSH6, PMS2, PTEN, and TP53

28 reviewed genetic variations associated with an increased risk of prostate cancer over 5 genes including BRCA2, PTEN, HRAS, CDH1, TP53

Who should get OncoSeq® C Screening done?

  • An individual who is diagnosed with the cancer
  • When there is a family history of cancer
  • When there is an increased risk of cancer
  • When you are worried about the risk of cancer

Sample Requirement

  • Buccal Swab/Saliva
How it Work

Relevant Syndromes Covered

Hereditary Breast, Ovarian and Prostate Cancer Syndrome

For more details about each panel and a complete list of syndromes, please contact us at 800 – GENOMICS (43666427)